drugset / Trial / NCT04030091

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

NCT04030091

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is an open label, prospective, randomised comparative, single center study. In the present study, the impact of a 12-week pulsatile insulin infusion therapy (PIT) with Humulin R 100 from

Timeline

Start
2019-09-06
Primary completion
2020-10-19
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 3 iu Intravenous